Can B Corp (NASC) stock
NASCOTCWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2024, quarter ended Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$0.01−0.00 (-1.32%)
Close on Oct 19, 2026Market cap $981.54KP/E –Yield –
Can B revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Can B's revenue for the twelve months ending Sep 30, 2024 was $1.03M, down 57.7% year over year. For fiscal 2023 it was $2.16M, down 67.8% from the year before. The highest annual figure on record is $6.69M in fiscal 2022.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $2.16M | -67.8% |
| FY2022 | Dec 31, 2022 | $6.69M | +45.2% |
| FY2021 | Dec 31, 2021 | $4.60M | +169.3% |
| FY2020 | Dec 31, 2020 | $1.71M | -25.8% |
| FY2019 | Dec 31, 2019 | $2.31M | +244.8% |
| FY2018 | Dec 31, 2018 | $668.60K | +444.7% |
| FY2017 | Dec 31, 2017 | $122.75K | +29.0% |
| FY2016 | Dec 31, 2016 | $95.15K | -13.8% |
| FY2015 | Dec 31, 2015 | $110.43K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2024 | Sep 30, 2024 | $15.27K | -96.4% |
| Q2 FY2024 | Jun 30, 2024 | $272.29K | -35.3% |
| Q1 FY2024 | Mar 31, 2024 | $369.10K | -60.7% |
| Q4 FY2023 | Dec 31, 2023 | $376.89K | -43.4% |
| Q3 FY2023 | Sep 30, 2023 | $418.96K | -85.5% |
| Q2 FY2023 | Jun 30, 2023 | $420.59K | -66.9% |
| Q1 FY2023 | Mar 31, 2023 | $939.31K | -49.5% |
| Q4 FY2022 | Dec 31, 2022 | $666.07K | -66.4% |
| Q3 FY2022 | Sep 30, 2022 | $2.89M | +51.2% |
| Q2 FY2022 | Jun 30, 2022 | $1.27M | +216.4% |
| Q1 FY2022 | Mar 31, 2022 | $1.86M | +506.1% |
| Q4 FY2021 | Dec 31, 2021 | $1.98M | +317.5% |
| Q3 FY2021 | Sep 30, 2021 | $1.91M | +315.8% |
| Q2 FY2021 | Jun 30, 2021 | $401.77K | +95.9% |
| Q1 FY2021 | Mar 31, 2021 | $306.94K | -46.1% |
| Q4 FY2020 | Dec 31, 2020 | $475.38K | -11.9% |
| Q3 FY2020 | Sep 30, 2020 | $459.50K | -25.3% |
| Q2 FY2020 | Jun 30, 2020 | $205.08K | -67.6% |
| Q1 FY2020 | Mar 31, 2020 | $569.71K | +10.2% |
| Q4 FY2019 | Dec 31, 2019 | $539.34K | +91.7% |
| Q3 FY2019 | Sep 30, 2019 | $615.42K | +276.8% |
| Q2 FY2019 | Jun 30, 2019 | $633.58K | +310.9% |
| Q1 FY2019 | Mar 31, 2019 | $517.16K | +641.2% |
| Q4 FY2018 | Dec 31, 2018 | $281.32K | +395.2% |
| Q3 FY2018 | Sep 30, 2018 | $163.33K | +639.1% |
| Q2 FY2018 | Jun 30, 2018 | $154.19K | +496.0% |
| Q1 FY2018 | Mar 31, 2018 | $69.77K | +288.2% |
| Q4 FY2017 | Dec 31, 2017 | $56.81K | +145.3% |
| Q3 FY2017 | Sep 30, 2017 | $22.10K | -9.2% |
| Q2 FY2017 | Jun 30, 2017 | $25.87K | +1.7% |
| Q1 FY2017 | Mar 31, 2017 | $17.97K | -19.1% |
| Q4 FY2016 | Dec 31, 2016 | $23.16K | -3.1% |
| Q3 FY2016 | Sep 30, 2016 | $24.33K | +31.2% |
| Q2 FY2016 | Jun 30, 2016 | $25.44K | -10.7% |
| Q1 FY2016 | Mar 31, 2016 | $22.23K | – |
| Q4 FY2015 | Dec 31, 2015 | $23.91K | – |
| Q3 FY2015 | Sep 30, 2015 | $18.54K | – |
| Q2 FY2015 | Jun 30, 2015 | $28.47K | – |
See a number that looks wrong?